IL159326A0 - Crystalline composition containing escitalopram - Google Patents

Crystalline composition containing escitalopram

Info

Publication number: IL159326A0
Authority: IL; Israel
Prior art keywords: composition containing; crystalline composition; containing escitalopram; escitalopram; crystalline
Prior art date: 2001-07-31

Application number

IL15932602A

Other languages

English (en)

Original Assignee

Lundbeck & Co As H

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-31

Filing date

2002-07-25

Publication date

2004-06-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8160647&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL159326(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-07-25 Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H

2004-06-01 Publication of IL159326A0 publication Critical patent/IL159326A0/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Psychiatry (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Neurosurgery (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Cephalosporin Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

IL15932602A 2001-07-31 2002-07-25 Crystalline composition containing escitalopram IL159326A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DKPA200101164		2001-07-31
PCT/DK2002/000513 WO2003011278A1 (en)	2001-07-31	2002-07-25	Crystalline composition containing escitalopram

Publications (1)

Publication Number	Publication Date
IL159326A0 true IL159326A0 (en)	2004-06-01

Family

ID=8160647

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL15932602A IL159326A0 (en)	2001-07-31	2002-07-25	Crystalline composition containing escitalopram
IL159326A IL159326A (en)	2001-07-31	2003-12-11	Crystalline composition containing escitalopram

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL159326A IL159326A (en)	2001-07-31	2003-12-11	Crystalline composition containing escitalopram

Country Status (40)

Country	Link
US (3)	US6916941B2 (pt)
EP (2)	EP1522539B1 (pt)
JP (4)	JP2005525993A (pt)
KR (1)	KR20040028947A (pt)
CN (2)	CN1660074A (pt)
AR (1)	AR034898A1 (pt)
AT (2)	ATE352546T1 (pt)
AU (1)	AU2002355624B2 (pt)
BG (1)	BG108571A (pt)
BR (1)	BR0206164A (pt)
CA (1)	CA2451915C (pt)
CO (1)	CO5560540A2 (pt)
CY (1)	CY1106413T1 (pt)
DE (2)	DE60202615T2 (pt)
DK (2)	DK1522539T3 (pt)
EA (1)	EA006213B1 (pt)
EG (1)	EG24206A (pt)
ES (2)	ES2233842T3 (pt)
HK (1)	HK1070000A1 (pt)
HR (2)	HRP20031073A2 (pt)
HU (1)	HUP0401946A2 (pt)
IL (2)	IL159326A0 (pt)
IS (1)	IS7077A (pt)
MA (1)	MA27349A1 (pt)
ME (1)	MEP2108A (pt)
MX (1)	MXPA04000849A (pt)
MY (1)	MY126238A (pt)
NO (1)	NO328346B1 (pt)
NZ (1)	NZ530157A (pt)
PE (1)	PE20030304A1 (pt)
PL (1)	PL366995A1 (pt)
PT (2)	PT1522539E (pt)
RS (1)	RS8304A (pt)
SI (1)	SI1414435T1 (pt)
TN (1)	TNSN04021A1 (pt)
TR (1)	TR200400189T2 (pt)
UA (1)	UA79930C2 (pt)
UY (1)	UY27404A1 (pt)
WO (1)	WO2003011278A1 (pt)
ZA (1)	ZA200309684B (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1142926C (zh)	1999-04-14	2004-03-24	H·隆德贝克有限公司	制备西酞普兰的方法
US20030232881A1 (en) *	2000-10-27	2003-12-18	H. Lundbeck A/S	Crystals of pharmaceutically acceptable salts of citalopram, methods of crystallization, and pharmaceutical compositions comprising them
US20030109577A1 (en) *	2000-10-27	2003-06-12	Ken Liljegren	Pharmaceutical composition containing citalopram
IL159326A0 (en)	2001-07-31	2004-06-01	Lundbeck & Co As H	Crystalline composition containing escitalopram
PE20040991A1 (es)	2002-08-12	2004-12-27	Lundbeck & Co As H	Separacion de intermediarios para la preparacion de escitalopram
TR200504022T1 (tr) *	2003-03-24	2006-08-21	Hetero Drugs Limited	(S)-sitalopram oksalatın yeni sıvı kristal formları.
US20040265375A1 (en) *	2003-04-16	2004-12-30	Platteeuw Johannes J.	Orally disintegrating tablets
TWI339651B (en) *	2004-02-12	2011-04-01	Lundbeck & Co As H	Method for the separation of intermediates which may be used for the preparation of escitalopram
US20050196453A1 (en) *	2004-03-05	2005-09-08	H. Lundbeck A/S	Crystalline composition containing escitalopram
WO2005084643A1 (en) *	2004-03-05	2005-09-15	H. Lundbeck A/S	Crystalline composition containing escitalopram oxalate
WO2006123243A2 (en) *	2005-05-20	2006-11-23	Aurobindo Pharma Limited	Pharmaceutical dosage forms comprising escitalopram in form of granules
TWI358407B (en) *	2005-06-22	2012-02-21	Lundbeck & Co As H	Crystalline base of escitalopram and orodispersibl
US7834201B2 (en)	2005-06-22	2010-11-16	H. Lundbeck A/S	Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
US20070098804A1 (en) *	2005-08-29	2007-05-03	Judith Aronhime	Solid particulate tadalafil having a bimodal particle size distribution
EA200801081A1 (ru)	2005-10-14	2008-10-30	Х. Лундбекк А/С	Способы лечения расстройств центральной нервной системы комбинацией малых доз эсциталопрама и бупропиона
US20070134322A1 (en) *	2005-12-14	2007-06-14	Forest Laboratories, Inc.	Modified and pulsatile release pharmaceutical formulations of escitalopram
GB0601286D0 (en)	2006-01-23	2006-03-01	Sandoz Ag	Asymmetric synthesis
WO2008059514A2 (en) *	2006-07-31	2008-05-22	Cadila Healthcare Limited	Process for preparing escitalopram
EP2086509A1 (en) *	2006-10-20	2009-08-12	Ratiopharm GmbH	Escitalopram and solid pharmaceutical composition comprising the same
US20090048336A1 (en) *	2007-08-17	2009-02-19	Naveen Kumar Kolla	Escitalopram oxalate powders
EP2291177A2 (en) *	2008-05-05	2011-03-09	Farmaprojects, S.A.	Stable pharmaceutical compositions and their processes for preparation suitable for industrial scale
EP2116231A1 (en)	2008-05-07	2009-11-11	Hexal Ag	Granulate comprising escitalopram oxalate
GR20080100696A (el)	2008-10-23	2010-05-13	Genepharm �.�.	Φαρμακοτεχνικη μορφη με βελτιωμενη γευση του φαρμακευτικα αποδεκτου αλατος εσιταλοπραμης
ITMI20120448A1 (it) *	2012-01-30	2013-07-31	Carthesia Sas	Composizione liofilizzata di escitalopram ossalato per somministrazione sublinguale
ITMI20120106A1 (it) *	2012-01-30	2013-07-31	Carthesia S A S	Pastiglie liofilizzate di escitalopram ossalato per somministrazione sublinguale
CN106397249A (zh) *	2015-08-03	2017-02-15	深圳信立泰药业股份有限公司	一种高稳定性lcz696结晶粉末及其制备方法
JP2018016569A (ja) *	2016-07-26	2018-02-01	株式会社トクヤマ	（１ｓ）−１−［３−（ジメチルアミノ）プロピル］−１−（４−フルオロフェニル）−１，３−ジヒドロイソベンゾフラン−５−カルボニトリル蓚酸塩の製造方法
JP6423133B1 (ja) *	2017-04-10	2018-11-14	東和薬品株式会社	エスシタロプラム医薬組成物
CN107441052A (zh) *	2017-06-21	2017-12-08	山东京卫制药有限公司	一种含有草酸艾司西酞普兰的片剂及其制备方法
KR102089737B1 (ko) *	2017-11-01	2020-03-16	한국화학연구원	에씨탈로프람을 함유한 미립구형 서방출 주사제 및 그의 제조방법
JP7453859B2 (ja)	2020-06-22	2024-03-21	東和薬品株式会社	エスシタロプラム錠剤

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1143702A (pt)	1965-03-18
GB1358915A (en)	1971-09-13	1974-07-03	Merck & Co Inc	Directly compressed tablet and composition therefor
GB1526331A (en) *	1976-01-14	1978-09-27	Kefalas As	Phthalanes
GB8419963D0 (en) *	1984-08-06	1984-09-12	Lundbeck & Co As H	Intermediate compound and method
DE3688827T2 (de)	1985-10-25	1994-03-31	Beecham Group Plc	Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel.
GB8814057D0 (en) *	1988-06-14	1988-07-20	Lundbeck & Co As H	New enantiomers & their isolation
US5296507A (en)	1990-09-06	1994-03-22	H.Lundbeck A/S	Treatment of cerbrovascular disorders
GB9325644D0 (en)	1993-12-15	1994-02-16	Smithkline Beecham Plc	Novel formulation
US5683720A (en)	1994-10-28	1997-11-04	Fuisz Technologies Ltd.	Liquiflash particles and method of making same
EP0714663A3 (en)	1994-11-28	1997-01-15	Lilly Co Eli	Potentiation of drug responses by serotonin 1A receptor antagonists
AU5966196A (en)	1995-06-08	1997-01-09	Eli Lilly And Company	Methods of treating cold and allergic rhinitis
DE1015416T1 (de)	1997-07-08	2000-10-05	Lundbeck A S Kobenhavn Valby H	Verfahren zur herstellung von citalopram
GB9714841D0 (en)	1997-07-14	1997-09-17	Smithkline Beecham Plc	Treatment method
US5980941A (en)	1997-08-20	1999-11-09	Fuisz Technologies Ltd.	Self-binding shearform compositions
US5840334A (en)	1997-08-20	1998-11-24	Fuisz Technologies Ltd.	Self-binding shearform compositions
US5869098A (en)	1997-08-20	1999-02-09	Fuisz Technologies Ltd.	Fast-dissolving comestible units formed under high-speed/high-pressure conditions
UA62985C2 (en)	1997-11-10	2004-01-15	Lunnbeck As H	A method for the preparation of citalopram
JP3813820B2 (ja) *	1997-11-11	2006-08-23	ハー・ルンドベック・アクチエゼルスカベット	シタロプラムの製造方法
WO2000023431A1 (en)	1998-10-20	2000-04-27	H. Lundbeck A/S	Method for the preparation of citalopram
TWI230618B (en) *	1998-12-15	2005-04-11	Gilead Sciences Inc	Pharmaceutical compositions of 9-[2-[[bis[(pivaloyloxy)methyl]phosphono]methoxy]ethyl]adenine and tablets or capsules containing the same
CN1142926C (zh)	1999-04-14	2004-03-24	H·隆德贝克有限公司	制备西酞普兰的方法
ITMI991579A1 (it)	1999-06-25	2001-01-15	Lundbeck & Co As H	Metodo per la preparazione di citalopram
AR021155A1 (es)	1999-07-08	2002-06-12	Lundbeck & Co As H	Tratamiento de desordenes neuroticos
CA2385749A1 (en) *	1999-09-28	2001-04-05	H. Lundbeck A/S	Melt granulated composition and modified release dosage form prepared from said composition
GB2357762B (en)	2000-03-13	2002-01-30	Lundbeck & Co As H	Crystalline base of citalopram
US6977306B2 (en)	2000-05-02	2005-12-20	Sumitomo Chemical Company, Limited	Citalopram hydrobromide crystal and method for crystallization thereof
US20030232881A1 (en) *	2000-10-27	2003-12-18	H. Lundbeck A/S	Crystals of pharmaceutically acceptable salts of citalopram, methods of crystallization, and pharmaceutical compositions comprising them
IL159326A0 (en)	2001-07-31	2004-06-01	Lundbeck & Co As H	Crystalline composition containing escitalopram

2002
- 2002-07-25 IL IL15932602A patent/IL159326A0/xx unknown
- 2002-07-25 ES ES02750846T patent/ES2233842T3/es not_active Expired - Lifetime
- 2002-07-25 PT PT04029282T patent/PT1522539E/pt unknown
- 2002-07-25 RS YU8304A patent/RS8304A/sr unknown
- 2002-07-25 ES ES04029282T patent/ES2280892T3/es not_active Expired - Lifetime
- 2002-07-25 CN CN2004100941660A patent/CN1660074A/zh active Pending
- 2002-07-25 ZA ZA200309684A patent/ZA200309684B/xx unknown
- 2002-07-25 UA UA20031212659A patent/UA79930C2/uk unknown
- 2002-07-25 DE DE60202615T patent/DE60202615T2/de not_active Revoked
- 2002-07-25 CA CA2451915A patent/CA2451915C/en not_active Expired - Fee Related
- 2002-07-25 EP EP04029282A patent/EP1522539B1/en not_active Revoked
- 2002-07-25 TR TR2004/00189T patent/TR200400189T2/xx unknown
- 2002-07-25 DK DK04029282T patent/DK1522539T3/da active
- 2002-07-25 KR KR10-2004-7001140A patent/KR20040028947A/ko not_active Application Discontinuation
- 2002-07-25 EP EP02750846A patent/EP1414435B1/en not_active Revoked
- 2002-07-25 EA EA200400243A patent/EA006213B1/ru not_active IP Right Cessation
- 2002-07-25 NZ NZ530157A patent/NZ530157A/en not_active IP Right Cessation
- 2002-07-25 JP JP2003516508A patent/JP2005525993A/ja active Pending
- 2002-07-25 DK DK02750846T patent/DK1414435T3/da active
- 2002-07-25 CN CNB028150317A patent/CN1311819C/zh not_active Expired - Lifetime
- 2002-07-25 PT PT02750846T patent/PT1414435E/pt unknown
- 2002-07-25 AU AU2002355624A patent/AU2002355624B2/en not_active Ceased
- 2002-07-25 BR BR0206164-3A patent/BR0206164A/pt not_active Application Discontinuation
- 2002-07-25 AT AT04029282T patent/ATE352546T1/de not_active IP Right Cessation
- 2002-07-25 MX MXPA04000849A patent/MXPA04000849A/es active IP Right Grant
- 2002-07-25 AR ARP020102808A patent/AR034898A1/es unknown
- 2002-07-25 SI SI200230091T patent/SI1414435T1/xx unknown
- 2002-07-25 HU HU0401946A patent/HUP0401946A2/hu unknown
- 2002-07-25 PL PL02366995A patent/PL366995A1/xx unknown
- 2002-07-25 AT AT02750846T patent/ATE286730T1/de active
- 2002-07-25 ME MEP-21/08A patent/MEP2108A/xx unknown
- 2002-07-25 WO PCT/DK2002/000513 patent/WO2003011278A1/en active Application Filing
- 2002-07-25 DE DE60217932T patent/DE60217932T2/de not_active Revoked
- 2002-07-26 PE PE2002000675A patent/PE20030304A1/es not_active Application Discontinuation
- 2002-07-28 EG EG2002070849A patent/EG24206A/xx active
- 2002-07-30 MY MYPI20022871A patent/MY126238A/en unknown
- 2002-07-30 UY UY27404A patent/UY27404A1/es not_active Application Discontinuation
2003
- 2003-03-31 US US10/403,453 patent/US6916941B2/en not_active Expired - Lifetime
- 2003-12-11 IL IL159326A patent/IL159326A/en unknown
- 2003-12-15 IS IS7077A patent/IS7077A/is unknown
- 2003-12-23 HR HR20031073A patent/HRP20031073A2/xx not_active Application Discontinuation
2004
- 2004-01-27 TN TNP2004000021A patent/TNSN04021A1/en unknown
- 2004-01-28 NO NO20040380A patent/NO328346B1/no not_active IP Right Cessation
- 2004-02-04 MA MA27512A patent/MA27349A1/fr unknown
- 2004-02-09 BG BG108571A patent/BG108571A/xx unknown
- 2004-02-25 CO CO04016758A patent/CO5560540A2/es not_active Application Discontinuation
2005
- 2005-02-07 US US11/053,641 patent/US7420069B2/en not_active Expired - Lifetime
- 2005-04-04 HK HK05102804A patent/HK1070000A1/xx not_active IP Right Cessation
2007
- 2007-03-23 CY CY20071100411T patent/CY1106413T1/el unknown
2008
- 2008-08-22 HR HR20080410A patent/HRPK20080410B3/xx not_active IP Right Cessation
- 2008-08-22 US US12/196,812 patent/US20080305164A1/en not_active Abandoned
2010
- 2010-03-16 JP JP2010059368A patent/JP4971477B2/ja not_active Expired - Lifetime
2011
- 2011-05-30 JP JP2011120483A patent/JP5192568B2/ja not_active Expired - Lifetime
2012
- 2012-07-26 JP JP2012166170A patent/JP5719811B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
MXPA04000849A (es)	2004-05-14
MA27349A1 (fr)	2005-06-01
HRP20080410A2 (en)	2008-10-31
PT1414435E (pt)	2005-05-31
UY27404A1 (es)	2003-02-28
IS7077A (is)	2003-12-15
EG24206A (en)	2008-10-21
WO2003011278A1 (en)	2003-02-13
HUP0401946A2 (hu)	2005-01-28
AR034898A1 (es)	2004-03-24
EP1414435A1 (en)	2004-05-06
HRP20031073A2 (en)	2004-04-30
JP2012211186A (ja)	2012-11-01
US20030212128A1 (en)	2003-11-13
AU2002355624B2 (en)	2006-02-02
BG108571A (en)	2005-02-28
CA2451915C (en)	2010-09-21
EP1522539A1 (en)	2005-04-13
EP1522539B1 (en)	2007-01-24
JP2011195591A (ja)	2011-10-06
DE60202615T2 (de)	2006-01-12
PT1522539E (pt)	2007-03-30
ES2280892T3 (es)	2007-09-16
DE60202615D1 (de)	2005-02-17
DK1414435T3 (da)	2005-05-09
HRPK20080410B3 (en)	2009-09-30
ATE352546T1 (de)	2007-02-15
CO5560540A2 (es)	2005-09-30
NZ530157A (en)	2007-06-29
NO20040380L (no)	2004-01-28
HK1070000A1 (en)	2005-06-10
SI1414435T1 (en)	2005-06-30
CN1536997A (zh)	2004-10-13
JP2005525993A (ja)	2005-09-02
BR0206164A (pt)	2003-10-28
CN1311819C (zh)	2007-04-25
TNSN04021A1 (en)	2006-06-01
US6916941B2 (en)	2005-07-12
DE60217932T2 (de)	2007-08-30
US20080305164A1 (en)	2008-12-11
TR200400189T2 (tr)	2004-12-21
ES2233842T3 (es)	2005-06-16
NO328346B1 (no)	2010-02-01
UA79930C2 (en)	2007-08-10
EA200400243A1 (ru)	2004-06-24
PE20030304A1 (es)	2003-03-27
CY1106413T1 (el)	2011-10-12
IL159326A (en)	2010-05-31
US7420069B2 (en)	2008-09-02
CA2451915A1 (en)	2003-02-13
KR20040028947A (ko)	2004-04-03
ZA200309684B (en)	2004-12-22
US20050147674A1 (en)	2005-07-07
EP1414435B1 (en)	2005-01-12
JP2010150283A (ja)	2010-07-08
DE60217932D1 (de)	2007-03-15
CN1660074A (zh)	2005-08-31
ATE286730T1 (de)	2005-01-15
PL366995A1 (en)	2005-02-07
MY126238A (en)	2006-09-29
MEP2108A (xx)	2010-02-10
JP4971477B2 (ja)	2012-07-11
JP5719811B2 (ja)	2015-05-20
EA006213B1 (ru)	2005-10-27
RS8304A (en)	2006-12-15
JP5192568B2 (ja)	2013-05-08
DK1522539T3 (da)	2007-05-07

Publication	Publication Date	Title
HK1070000A1 (en)	2005-06-10	Crystalline composition containing escitalopram
PL367134A1 (en)	2005-02-21	Novel composition
GB0114069D0 (en)	2001-08-01	Composition
GB0107651D0 (en)	2001-05-16	Composition
GB0122113D0 (en)	2001-10-31	Composition
EP1364646A4 (en)	2005-08-03	FENOFIBRATE CONTAINING COMPOSITION
GB0115679D0 (en)	2001-08-22	Composition
GB0130110D0 (en)	2002-02-06	Composition
GB0117305D0 (en)	2001-09-05	Composition
GB0126081D0 (en)	2001-12-19	Composition
GB0121454D0 (en)	2001-10-24	Composition
GB0126085D0 (en)	2001-12-19	Composition
GB0119470D0 (en)	2001-10-03	Novel composition
GB0119468D0 (en)	2001-10-03	Novel composition
GB0100458D0 (en)	2001-02-21	Novel composition
GB0108226D0 (en)	2001-05-23	Novel crystalline forms
GB0105328D0 (en)	2001-04-18	Composition
GB0112688D0 (en)	2001-07-18	Composition
GB0113366D0 (en)	2001-07-25	Composition
GB0112651D0 (en)	2001-07-18	Composition
GB0114067D0 (en)	2001-08-01	Composition
GB0112500D0 (en)	2001-07-11	Composition
GB0115076D0 (en)	2001-08-15	Composition
GB0106007D0 (en)	2001-05-02	Composition
GB0115939D0 (en)	2001-08-22	Composition